Recent lessons for the management of bone and joint infections

Journal of Infection

Volumn 68, Issue SUPPL1, 2014, Pages

  Kaplan, Sheldon L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Osteomyelitis; Septic arthritis; Staphylococcus aureus

Indexed keywords

ANTICOAGULANT AGENT; C REACTIVE PROTEIN; CEFTAROLINE; CEPHALOSPORIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; GENTAMICIN; LINEZOLID; NAFCILLIN; OXACILLIN; RIFAMPICIN; VANCOMYCIN;

ABSCESS DRAINAGE; ARTICLE; BACTERIAL ARTHRITIS; BACTERIUM ISOLATE; BLOOD CULTURE; BONE MARROW SUPPRESSION; CLINICAL FEATURE; COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; KINGELLA KINGAE; LEUKOCYTE COUNT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PATHOLOGIC FRACTURE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; VEIN THROMBOSIS;

OSTEOMYELITIS; SEPTIC ARTHRITIS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; OSTEOMYELITIS;

EID: 84889666555     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.09.014     Document Type: Article

References (47)

1. Arnold S.R., Elias D., Buckingham S.C., Thomas E.D., Novais E., Arkader A., et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community- associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop 2006, 26(6):703-708.
2. Saavedra-Lozano J., Mejias A., Ahmad N., Peromingo E., Ardura M.I., Guillen S., et al. Changing trends in acute osteomyelitis in children: impact of methicillin-resistant Staphylococcus aureus infections. J Pediatr Orthop 2008, 28(5):569-575.
3. Bocchini C.E., Hulten K.G., Mason E.O., Gonzalez B.E., Hammerman W.A., Kaplan S.L. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 2006, 117(2):433-440.
4. Sdougkos G., Chini V., Papanastasiou D.A., Christodoulou G., Tagaris G., Dimitracopoulos G., et al. Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin as a cause of acute osteomyelitis in children. Clin Microbiol Infect 2007.
5. Goergens E.D., McEvoy A., Watson M., Barrett I.R. Acute osteomyelitis and septic arthritis in children. J Paediatr Child Health 2005, 41(1-2):59-62.
6. Yamagishi Y., Togawa M., Shiomi M. Septic arthritis and acute hematogenous osteomyelitis in childhood at a tertiary hospital in Japan. Pediatr Int 2009, 51(3):371-376.
7. David M.Z., Daum R.S. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010, 23(3):616-687.
8. Nimmo G.R. USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2012.
9. Yagupsky P., Porsch E., St Geme J.W. Kingella kingae: an emerging pathogen in young children. Pediatrics 2011, 127(3):557-565.
10. Verdier I., Gayet-Ageron A., Ploton C., Taylor P., Benito Y., Freydiere A.M., et al. Contribution of a broad range polymerase chain reaction to the diagnosis of osteoarticular infections caused by Kingella kingae: description of twenty-four recent pediatric diagnoses. Pediatr Infect Dis J 2005, 24(8):692-696.
11. Chometon S., Benito Y., Chaker M., Boisset S., Ploton C., Berard J., et al. Specific real-time polymerase chain reaction places Kingella kingae as the most common cause of osteoarticular infections in young children. Pediatr Infect Dis J 2007, 26(5):377-381.
12. Amit U., Porat N., Basmaci R., Bidet P., Bonacorsi S., Dagan R., et al. Genotyping of invasive Kingella kingae isolates reveals predominant clones and association with specific clinical syndromes. Clin Infect Dis 2012, 55(8):1074-1079.
13. Bradley J.S., Kaplan S.L., Tan T.Q., Barson W.J., Arditi M., Schutze G.E., et al. Pediatric pneumococcal bone and joint infections. The pediatric multicenter pneumococcal surveillance study group (PMPSSG). Pediatrics 1998, 102(6):1376-1382.
14. Kaplan S., Barson W.J., Ling-Lin P., et al. Early trends for invasive pneumococcal infections in children following the introduction of the 13-Valent pneumococcal conjugate vaccine. Pediatr Infec Dis J 2013, 32:203-207.
15. Lemaitre C., Ferroni A., Doit C., Vu-Thien H., Glorion C., Raymond J., et al. Pediatric osteoarticular infections caused by Streptococcus pneumoniae before and after the introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis 2012, 31(10):2773-2781.
16. Martinez-Aguilar G., Avalos-Mishaan A., Hulten K., Hammerman W., Mason E.O., Kaplan S.L. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004, 23(8):701-706.
17. Williams D.J., Deis J.N., Tardy J., Creech C.B. Culture-negative osteoarticular infections in the era of community-associated methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2011, 30(6):523-525.
18. Dohin B., Gillet Y., Kohler R., Lina G., Vandenesch F., Vanhems P., et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 2007, 26(11):1042-1048.
19. Cremieux A.C., Dumitrescu O., Lina G., Vallee C., Cote J.F., Muffat-Joly M., et al. Panton- valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One 2009, 4(9):e7204.
20. Krogstad P. Osteomyelitis. Textbook of pediatric infectious diseases 2009, 725-742. Elsevier. 6 ed. R.D. Feigin, J.D. Cherry, G.J. Demmler-Harrison, S.L. Kaplan (Eds.).
21. Perlman M.H., Patzakis M.J., Kumar P.J., Holtom P. The incidence of joint involvement with adjacent osteomyelitis in pediatric patients. J Pediatr Orthop 2000, 20(1):40-43.
22. Carrillo-Marquez M.A., Hulten K.G., Hammerman W., Mason E.O., Kaplan S.L. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J 2009, 28(12):1076-1080.
23. Browne L.P., Mason E.O., Kaplan S.L., Cassady C.I., Krishnamurthy R., Guillerman R.P. Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediatr Radiol 2008, 38(8):841-847.
24. Liu C., Bayer A., Cosgrove S.E., Daum R.S., Fridkin S.K., Gorwitz R.J., et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011, 52(3):285-292.
25. Frymoyer A., Hersh A.L., Benet L.Z., Guglielmo B.J. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J 2009, 28(5):398-402.
26. Mason E.O., Lamberth L.B., Hammerman W.A., Hulten K.G., Versalovic J., Kaplan S.L. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol 2009, 47(6):1628-1630.
27. Jimenez-Truque N., Thomsen I., Saye E., Creech C.B. Should higher vancomycin trough levels be targeted for invasive community-acquired methicillin-resistant Staphylococcus aureus infections in children?. Pediatr Infect Dis J 2010, 29(4):368-370.
28. Martinez-Aguilar G., Hammerman W.A., Mason E.O., Kaplan S.L. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin- susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003, 22(7):593-598.
29. Chen C.J., Chiu C.H., Lin T.Y., Lee Z.L., Yang W.E., Huang Y.C. Experience with linezolid therapy in children with osteoarticular infections. Pediatr Infect Dis J 2007, 26(11):985-988.
30. Erturan G., Holme H., Smith R., Dodds R., Iyer S. Successful use of daptomycin in Panton- Valentine leucocidin positive Staphylococcus aureus paediatric osteomyelitis. Int J Surg Case Rep 2012, 3(7):238-241.
31. Messina A.F., Namtu K., Guild M., Dumois J.A., Berman D.M. Trimethoprim-sulfamethoxazole therapy for children with acute osteomyelitis. Pediatr Infect Dis J 2011, 30(12):1019-1021.
32. Peltola H., Paakkonen M., Kallio P., Kallio M.J.T. Short-versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positve cases. Pediatr Infec Dis J 2013, the Osteomyelitis-Septic Arthritis Study Group, [in press].
33. Peltola H., Paakkonen M., Kallio P., Kallio M.J. Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis. Clin Infect Dis 2009, 48(9):1201-1210.
34. Ruebner R., Keren R., Coffin S., Chu J., Horn D., Zaoutis T.E. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics 2006, 117(4):1210-1215.
35. Peltola H., Paakkonen M., Kallio P., Kallio M.J.T. The osteomyelitis-septic arthritis study group. Short-versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positve cases. Pediatr Infec Dis J 2010, 29:1123-1128.
36. Arnold J.C., Cannavino C.R., Ross M.K., Westley B., Miller T.C., Riffenburgh R.H., et al. Acute bacterial osteoarticular infections: eight-year analysis of C-reactive protein for oral step- down therapy. Pediatrics 2012, 130(4):e821-e828.
37. Farrell D.J., Castanheira M., Mendes R.E., Sader H.S., Jones R.N. Invitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010). Clin Infect Dis 2012, 55(Suppl. 3):S206-S214.
38. Corey G.R., Wilcox M.H., Talbot G.H., Thye D., Friedland D., Baculik T. CANVAS 1: the first phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother 2010, 65(Suppl. 4):iv41-iv51.
39. Wilcox M.H., Corey G.R., Talbot G.H., Thye D., Friedland D., Baculik T. CANVAS 2: the second phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother 2010, 65(Suppl. 4):iv53-iv65.
40. Jacqueline C., Amador G., Caillon J., Le Mabecque V., Batard E., Miegeville A.F., et al. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin- resistant Staphylococcus aureus acute osteomyelitis. J Antimicrob Chemother 2010, 65(8):1749-1752.
41. Lin J.C., Aung G., Thomas A., Jahng M., Johns S., Fierer J. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients. J Infect Chemother 2012.
42. Gonzalez B.E., Teruya J., Mahoney D.H., Hulten K.G., Edwards R., Lamberth L.B., et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 2006, 117(5):1673-1679.
43. Crary S.E., Buchanan G.R., Drake C.E., Journeycake J.M. Venous thrombosis and thromboembolism in children with osteomyelitis. J Pediatr 2006, 149(4):537-541.
44. Nourse C., Starr M., Munckhof W. Community-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management. J Paediatr Child Health 2007, 43(10):656-661.
45. Cunnington A., Brick T., Cooper M., Danin J., Hunt D., Jeanes A., et al. Severe invasive Panton-Valentine leucocidin positive Staphylococcus aureus infections in children in London, UK. J Infect 2009, 59(1):28-36.
46. Banchereau R., Jordan-Villegas A., Ardura M., Mejias A., Baldwin N., Xu H., et al. Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PLoS One 2012, 7(4):e34390.
47. Belthur M.V., Birchansky S.B., Verdugo A.A., Mason E.O., Hulten K.G., Kaplan S.L., et al. Pathologic fractures in children with acute Staphylococcus aureus osteomyelitis. J Bone Jt Surg Am 2012, 94(1):34-42.